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Chlamydia trachomatis is the most common bacterial sexually transmitted infection, causing 
significant morbidity and economic burden. Strategies like national screening programs or home-
testing kits were introduced in some developed countries, yet their effectiveness remains 
controversial. This systematic review examined reviews of chlamydia screening interventions to 
assess their effectiveness and the elements that contribute to their success to guide public policy 
and future research. The review assessed English material published after year 2000 in PubMed, 
Cochrane Library, the British Nursing Index, Medical Database, and Sociological Abstract, in 
addition to World Health Organization Global Health Sector Strategies, the European Center for 
Disease Prevention and Control guidelines, and PROSPERO. Systematic reviews that focused on 
chlamydia screening interventions were included. Using the socio-ecological model, we 
examined the levels of interventions that may affect the uptake of chlamydia screening. 19 
systematic reviews were included. Self-collection in home-testing kits significantly increased 
screening among females 14-50 years of age. At the organizational level, using electronic health 
records and not creating additional costs facilitated testing. At the community level, outreach 
interventions in community/parent centers and homeless shelters reached high screening rates. At 
the policy level, interventions with educational and advisory elements could result in significant 
improvements in screening rates.  
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Chlamydia trachomatis is the most common bacterial sexually transmitted infection and causes 
significant morbidity and economic burden globally 
1
. There are approximately 131 million new 
cases of chlamydial infection occurring in individuals aged 15-49 years annually, with an 
incidence rate of 38 per 1000 females and 33 per 1000 males. Among the non-viral sexually 
transmitted infections, chlamydia is the most costly infection, which costs the US healthcare 




The majority of chlamydia infections are asymptomatic with only 30% of women and 10% of 
men develop symptoms 
3
. Therefore, infected people often do not seek testing and are unaware 
of their infection 
4
. The symptoms of uncomplicated chlamydia infection in women include 
abnormal vaginal discharge and post-intercourse bleeding 
1
. Chlamydia trachomatis is also an 
important cause of pelvic inflammatory disease (PID) 
5
. A community-based study found that the 
annual incidence of PID among women with untreated chlamydia was about 10% 
6
. Other 
reproductive sequelae of chlamydia include infertility, ectopic pregnancy and chronic pelvic pain 
5
. The reported infertility rate after one episode of PID was 8% and it increases to 38% after 
three PID episodes 
7
. Chlamydia infection is also associated with negative psychosocial impact 




To reduce the burden of chlamydia control strategies a number of developed countries have 
implemented national screening programs 
10
, opportunistic screening for women <25 years 
11,12
, 
and targeted screening 
13
. England initiated their National Chlamydia screening program where 
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and community pharmacies. For sustainable benefits to occur, screening and follow-ups should 
be regular 
14
. Such requirements may be difficult as the target population must utilize health 
service regularly and health providers must offer the tests at appropriate intervals. Administrative 
systems also need to track individuals who attend various health venues 
15
. The introduction of 
quick and non-invasive testing methods such as nucleic acid amplification tests has allowed 
testing to be done in more convenient and out-of-clinic settings however chlamydia testing rates 
remain sub-optimal 
16
. Barriers that lead to continued low screening rates include hesitation and 





There is an abundance of literature relating to improving the rates of chlamydia screening. 
Certain interventions target patients while others target the healthcare providers. The 
heterogeneity of chlamydia screening interventions make clinicians and researchers difficult to 
determine which are effective.  Hence there is a lack of consensus on the most effective way to 
increase chlamydia screening. To address this issue we carried out a systematic review of 
systematic review articles, of chlamydia screening, in order to guide our public health policy and 
research in the area.  
 
Methods  
We conducted this systematic review of systematic reviews in accordance with the guideline of 
the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). The 
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Information Sources and Search strategy 
Five databases were used to identify review articles that have evaluate chlamydia screening 
intervention. They are PubMed, Cochrane Library, the British Nursing Index, Medical Database, 
and Sociological Abstract via ProQuest. Searches in PubMed were conducted with the Medical 
Subject Headings (MeSH) terms of “Chlamydia” and “mass screening” then filtered for 
systematic reviews and meta-analysis. In the Cochrane library, the advanced search function was 
used for the key words “chlamydia” and “screening”. In ProQuest, advanced search was carried 
out for the key words “chlamydia”, “mass screening”, and “systematic review”.   
 
Besides, the reference lists of the World Health Organization Global Health Sector Strategies and 
the European Center for Disease Prevention and Control guidelines were screened. PROSPERO 
database was also searched. Experts in our network were approached for suggestions of relevant 
papers.   
 
Inclusion Criteria  
We only included systematic reviews and meta-analysis published in English after 2000 because 
nucleic acid amplification test diagnostic technology was not introduced until then. Interventions 
must focus on Chlamydia screening (studies regarding sexually transmitted infection screening 
were accepted as long as chlamydia is included). Interventions must have one or more of these 
outcome measures: number of chlamydia tests, testing rate, retesting rate, and/or treatment rate 
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One author (Stephanie Lau) screened the titles and abstracts and two authors (Stephanie Lau and 
Edmond Choi) independently conducted full text screening and data extraction. Discrepancies 
were resolved through discussion and input from another author (William Wong).  
 
Data Extraction 
A raw data extraction sheet was created and included information such as target populations, 
settings, type of testing, number of people tested, prevalence, number of people treated, 
effectiveness, and barriers. The data extraction summary sheet is available in the appendix.  
 
Quality Assessment  
The quality of the included papers was assessed using the validated scale Assessment of Multiple 
Systematic Reviews (AMSTAR). It provides a 16-item checklist on the quality of systematic 
review methodology.  
 
Analysis  
The socio-ecological model was used to organize the interventions (Figure 1). The socio-
ecological model is a systems model with multiple levels of influence including interpersonal, 
organizational, community, and policy levels. Interventions based on the individuals’ 
characteristics aim to influence their knowledge, attitude, and beliefs towards a health behavior. 
Interventions at the interpersonal level influence social norms to overcome individual barriers. 
Involved parties include friends, family, community health workers, and health service 
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departments, and health clinics. Interventions in the community level try to leverage resources 
and encourage the participation of community-level institutions. Interventions at the policy level 
aim to create systemic changes. Health intervention developers often utilize this model to ensure 






200 studies were identified in the initial search of the databases and an additional 5 studies were 
identified through other sources. During the title screen, 148 studies were excluded because their 
titles did not mention that it was a systematic review, was not about sexually transmitted 
infections, or was not in English. During the abstract screen, 33 further studies were excluded 
because the abstract did not mention anything related to chlamydia screening and testing. 24 
reviews were assessed by full text screen in which five was excluded to result in the final 
inclusion of 19 reviews. The study details are shown in Web Table 1 One study was excluded 
because it described itself as a review but was ultimately not a systematic review. Two studies 
were excluded because it was regarding diagnostic tools for detecting chlamydia. Two studies 
were excluded because it was about rescreening (Figure 2).  
 
Quality Assessment 
Papers were marked out of a score of 16 and categorized into groups of low quality (0-5.5 score), 
medium quality (6-11.5 score), and high quality (≥12 score). Eleven systematic reviews were of 
low quality, nine of medium quality, and one of high quality. Twelve papers did not define 
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and one provided the list without justifications. One review reported funding information. Four 
utilized a satisfactory risk of bias technique for included studies while one obtained a “partial 
yes” in this criterion.  
 
Individual and Interpersonal Levels  
The systematic review by Chacko et al. focused on both health provider-based and client-
initiated chlamydia screening practices in asymptomatic young women in the United States 
20
. 
The review revealed that the screening of sexually active women under the age of 20 was the top 
priority. However, the authors of the review pointed out that it was challenging to evaluate the 
effectiveness of health provider-based screening programs because of the large size of program, 
variations in prevalence rates in populations targeted and the criteria used to determine 
effectiveness 
20
. Besides, the review found that there was a marked absence of programs and no 
publication describing intervention to foster client-initiated screening behaviors among 





A systematic review by Odesanmi et al. compared the screening uptake levels of home-based 
self-sampling and clinic-based specimen collection for Chlamydia trachomatis in females aged 
14-50 years old 
21
. The review only included randomized control trials. Self-collection is where 
people bring a kit home and send the sample to a testing facility without needing to attend a 
health facility 
21
. The review supported the use of home sampling to increase screening uptake 
but cost-effectiveness should be further investigated 
21
. Furthermore, the review reported a 
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review only focused on the home-based screening strategy and divided home-based screening 
into seven groups according to test kit and specimen delivery methods. The highest median 
specimen return rate was in outreach programs in which participants were approached at home 
with immediate collection of specimens (96.5%), programs providing home testing kits only on 
invitation acceptance (78.9%), home testing kits sent along with an invitation (32.9%), home 
testing kits requested without an invitation (31.8%), home testing kit offered in person (21.4%), 
and home testing kits picked up at specific locations (18.6%) 
22
. However, the interventions 
targeted a wide range of target populations hence comparison between each program may not be 
valid. Nonetheless, this review shows that self-collection programs have been conducted in a 
variety of countries and with different delivery methods, suggesting that home-based testing is a 
feasible and acceptable chlamydia screening method. However, further studies regarding its cost-




Organizational Level  
A systematic review by Taylor et al. categorized screening interventions into levels of 
effectiveness as measured by the absolute difference in percent of target population screened. 
Effective and low-cost interventions (<USD$1,000) included strategic placement of specimen 
collection materials, routine consultation collection, and electronic health records use. Effectives 
and low-moderate costs interventions ($USD<1,001-10,000) utilized patient reminder strategies 
such as postcards and calls. Effective and high costs ($USD$10,001-100,000) interventions 
involved dedicated screening staff. The authors concluded there is a variety of effective and cost-
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Interventions targeting females resulting in significant increases in screening rates include 
linking screening to pap smears (6.9% vs. 4.5%), computer alerts for doctors (15.5% vs. 12.4%), 
and free sexual health consultation (16.8% vs. 13.2%) 
24-26
. Screening program initiation is 
associated with chlamydia infection reduction and screening women with a certain range of risk 
factors reduces PID incidence for 1-year 
27,28
. Challenges in implementing healthcare provider 
screening interventions include lack of protocols of urine sample obtainment, insufficient 
knowledge about chlamydia and urine-based tests, and reluctance of staff to be engaged in 
adolescent sexually transmitted infection screening 
29
. The effectiveness and feasibility of 
screening for chlamydia in emergency departments has also been examined 
30
. Prevalence of 
emergency department patients was high (9.1-9.5%) 
28,31
. Barriers include finding a location for 
screening in the emergency department, clinician’s willingness and time constraints, and 




The systematic review by Gudka et al. examined pharmacy-based screening interventions 
37
. 
Return rates were high in studies with 47% in England, 63.9% in Scotland, 28% in Australia, and 
38% in the United States 
38-41
. Major barriers of pharmacy-based screening included having to 
return the specimen to designated sites and lack of privacy 
37,41
 for patients and increased 
workload or feeling uncomfortable when offering the test, and lack of in store advertising for 
pharmacists 
42
. The major benefits for patients included convenience, anonymity and no need for 
appointment, affordability 
36
, shorter waiting times, and friendly non-judgmental attitude of 
pharmacists 
43
. It was concluded that chlamydia screening in community pharmacies were 
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In a review by Bernstein et al., screening interventions in non-clinic settings were examined 
44
. 
The review revealed that high number of tests could be carried out in correctional settings and 
identified a large amount of asymptomatic infections. The total number of people approached 
was unavailable but high prevalence was found amongst adolescent girls in juvenile detention 
centers in Southern City (24.7%), Georgia (16.8%), and California (13.0%) 
45
. Other community-
based screening included homeless shelters, family court, and mobile van but they identified few 
new infections 
46-48
. High chlamydia prevalence was also found when screening in educational 
settings 
49
. The prevalence was 12.4% for males and females in a classroom-based strategy, 
18.8% for females in school-based health clinic, 15.6% for male and females in other school 
locations, and 15.0% in clinical session screening 
47,50-52
. Chlamydial screening in educational 





In the systematic review by Hengel et al., outreach interventions targeting young people aged 15-
29 years, men who have sex with men, and sex workers were identified 
53
. Amongst the outreach 
settings, the highest participation rate was in community venues such as community centers, 
parenting centers, and homeless shelters (81.4%) and social venues such as sport venues or bars 
(80.4%). In interventions targeting adolescents and young adults, Gold et al. found a high testing 
rate (75.2%, tests = 92) in a screening program in a football club changing room in Australia 
54
. 
High testing rates were also found in community venues targeting dropouts, new immigrants, 
and vocational school students in the Netherlands (79.6%, tests = 74) 
52
. Low participation rates 
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(10.4% and 24.3%, n=2) 
55
. The authors concluded that chlamydial outreach programs are able to 
result in high participation rates but with limited reach. Settings that resulted in higher 




Policy Level  
Education and advisory  
In the systematic review by Ginige et. al., a cluster randomized control trial assessing the 
effectiveness of an educational package in general practitioners in Belgium was analyzed 
18
. The 
target population was females aged below 35 years old 
56
. The intervention included a stimulated 
consultation and text messages regarding communication skills. The intervention group 
performed significantly better by carrying out more screening (median 6 patients per general 
practitioner vs. 3 patients per general practitioner, p = 0.035) 
57
. Another study investigated the 
effectiveness of having a health advisor in primary healthcare centers to increase awareness of 
chlamydia and to train the staff in Scotland. Testing rates in the intervention centers was 
significantly higher than those in the control (120%, vs 11%, p=<0.001). However, the 




Allison et al. carried out a study regarding the effectiveness of an internet-based continuing 
medical education to increase chlamydia screening by primary care physicians in the US. The 
continuing medical education course consisted of 4 modules over 3 months. The chlamydia 
screening rates for before, during and after the intervention were 16.2%, 13.3%, and 15.5% for 
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System-level changes in clinical practice  
In the same systematic review by Ginige et al. a randomized control trial assessing the 
effectiveness of a multi-phased intervention aimed to result in system-level changes in clinical 
practice regarding chlamydia screening was analyzed 
43
. The intervention consisted of four 
stages where the first stage was engagement with the organization’s leaders to investigate the 
discrepancy between current and best practice. The second stage involved the formation of 
adolescent care teams, a model for practice change, and a staff toolkit. The third stage involved 
monthly meetings between clinic team members. The final stage developed performance 
indicators. The intervention clinics saw a significant number of females ages 14-18 screened as 
compared to the control clinics (478 of 1017 vs 203 of 1194, p<0.001) 
47
. The authors concluded 
that there is a variety of ways to increase chlamydia screening but more randomized control trials 
are needed.   
 
Discussion  
Adolescent girls have always been the targets of screening programs but high chlamydial 
prevalence was also found in adolescent boys 
58,59
. Screening all or only high-risk adolescents 
have strong implications on monetary and human resources. Even if mass screening for 
adolescents is implemented, it is difficult to ensure the acceptance of the target population. The 
Centers for Disease Control and Prevention in the United States has recommended annual 
screening of women under age 26 since 1993 but less than half was screened in 2012 
44,60
 . At-
risk individuals such as women, adolescents, and those entering juvenile detention centers are 
often missed due to the lack of awareness in healthcare providers and limited resources 
45
. Young 
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chlamydia has been found 
20,46,59
. The Centers for Disease Control and Prevention has 
recommended for the universal screening of females during intake in juvenile correctional 
services and screening rates increased from 55%-58% from 2005-2008 
21
. Therefore, the 
questions are how to promote chlamydia infection awareness; how to reach the target population; 
and what environment changes encourage screening.  
 
While asymptomatic individuals are unlikely to obtain a routine check-up, clinicians also 
admitted to being hesitant in screening sexually active asymptomatic females 
61
. High-risk 
population should be linked to different health contacts such as pap smears, sexual health 
consultations or in pharmacy. Self-collection was found to significantly increase uptake of 
screening and was preferred over clinic-based testing in women aged 14-50 years 
62
. Self-
collection strategies should be promoted to adolescents via social media because social media is 
a popular portal for teenagers to exchange and share information 
63
. Social media interventions 
have been shown to be effective in significantly increasing syphilis and human 
immunodeficiency viruses testing in youth and in promoting human immunodeficiency viruses 
testing in men who have sex with men 
15,55
. However, the effectiveness of social media 
interventions has not been demonstrated for chlamydia testing. This calls for further research in 
social media campaigns to increase chlamydia testing amongst adolescents. Another approach is 
to implement structural changes to alter the attitudes of healthcare providers in that they make 
testing adolescents a priority. Healthcare providers should also receive proper training so that 
they are able to approach adolescent patients confidently for chlamydia screening. Structural 
interventions mentioned previously did not focus on adolescents hence development of 
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In essence, we want to know whether screening interventions are able to reduce chlamydia’s 
disease burden. Some studies revealed that chlamydia screening reduced chlamydia infections 
and that screening women with a certain range of risk factors reduced PID incidence, other 
studies claim a lack of evidence in supporting opportunistic screening in the general population 
below 25 years of age 
65,66
. While our review identified a large number of studies of chlamydia 
screening programs, most studies did not report data on chlamydia associated morbidity. We are 
not able to determine the impact of chlamydia screening on chlamydia associated morbidity. As 
we relied on the analysis and data presented by primary authors, this exclusion is sub-optimal. 
The lack of evidence on the effectiveness of chlamydia screening programs in reducing disease 
burden has caused several countries to focus on case identification and management 
67
. A recent 
review has suggested a shift from an infection-based focus to increase screening uptake in 
asymptomatic populations, to a health outcomes-based focus to improve case detection among 
high-risk populations and case management 
66
. Greater emphases need to be on strategies for 
infected individuals to minimize re-infection such as improving partner notification, treatment of 




Our methodology has a few limitations. Firstly, it depended on the inclusion and analysis of 
primary studies by the review’s authors. Secondly, included reviews differed significantly in 
terms of intervention design, target populations, settings and study outcomes. Therefore, the 
heterogeneity of the included systematic reviews has made comparison of effectiveness difficult. 
Apart from screening coverage and prevalence, other data regarding treatment, partner 
management, and retesting which is vital in determining its success, was often unavailable. 
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such as cultural attitudes, government policies, and differences in healthcare system could have 
effects on the outcomes.  
 
Conclusion  
There is evidence that shows the most important factor that determines the level of chlamydia 
screening was age. Therefore, national programs should focus on young males and females in the 
general population rather than individuals with high-risk characteristics. Reminders and outreach 
in certain community settings increased screening, but further information regarding cost-
effectiveness is needed. Four interventions at the policy level were found to be effective; while 
the interventions differ, they share similar educational, advisory, and supervisory elements. 
Structural interventions are vital in changing the attitudes and awareness of chlamydia screening 
to result in systemic change. Therefore, initiatives to train healthcare providers in carrying out 
appropriate testing for adolescents is needed. 
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Figure 1: The socio-ecological model 
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